We also compared the effect of dasatinib plus U0126 with the combination of dasatinib, U0126, and PS‐1145 on the capacity of CML CD34+ cells to form colonies in methylcellulose assays (Fig. 6A). Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.